21.10.Z - Manufacture of basic pharmaceutical substances
20 - Manufacture of chemicals and chemical products
20.15.Z - Manufacture of fertilisers and nitrogen compounds
46 - Wholesale trade, except of motor vehicles and motorcycles
46.75.Z - Wholesale of chemical products
47 - Retail trade, except motor vehicle retail
70.22.Z - Business and other management consultancy activities
71 - Architectural and engineering activities; technical testing and analysis
72 - Scientific research and development
77 - Rental and leasing activities
2022 | 2023 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | -1,9 | -1433,4 |
EBITDA | 0,1 | -1,8 | -1346,1 |
Short time liabilities | 1 | 0,4 | -60,3 |
Equity capital | 2 | 0,1 | -92,7 |
Operating profit (EBIT) | 0,1 | -1,9 | -1952,3 |
Assets | 3,1 | 0,6 | -81,7 |
Net profit (loss) | 0,1 | -1,9 | -1653,7 |
Cash | 0,6 | 0 | -97,7 |
Net income from sale | 5,3 | 0,4 | -92,8 |
Liabilities and provisions for liabilities | 1 | 0,4 | -60,3 |
Working assets | 2,9 | 0,5 | -81,5 |
Depreciation | 0 | 0 | 7 |
% | % | p.p. | |
Profitability of capital | 6 | -1268,6 | -1274,6 |
Equity capital to total assets | 66 | 26,3 | -39,7 |
Gross profit margin | 2,6 | -484,1 | -486,7 |
EBITDA Margin | 2,7 | -470,1 | -472,8 |
Days | Days | Days | |
Short term commitment turnover cycle | 71 | 390 | 319 |
Current financial liquidity indicator | 2.7918035984039307 | 1.3029550313949585 | -1,5 |
Net dept to EBITDA | -4.370270729064941 | 0.008099053986370564 | 4,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane